- News Home
12 December 2013 1:00 pm ,
Vol. 342 ,
Evolutionary biologists have long studied how the Mexican tetra, a drab fish that lives in rivers and creeks but has...
Victorian astronomers spent countless hours laboriously charting the positions of stars in the sky. Such sky mapping,...
In an ambitious project to study 1000 years of sickness and health, researchers are excavating the graveyard of the now...
Stefan Behnisch has won awards for designing science labs and other buildings that are smart, sustainable, and...
The iconic 125-year-old Lick Observatory on Mount Hamilton near San Jose, California, is facing the threat of closure...
Recent results from the Curiosity Mars rover have helped scientists formulate a plan for the next phase of its mission...
A new, remarkably powerful drug that cripples the hepatitis C virus (HCV) came to market last week, but it sells for $...
In pretoothbrush populations, gumlines would often be marred by a thick, visible crust of calcium phosphate, food...
- 12 December 2013 1:00 pm , Vol. 342 , #6164
- About Us
Live Chat: New Therapies for Mental Illness
9 October 2012 8:51 am
See below for the chat box. Join us next Wednesday at 3 p.m. EDT for a live conversation with leading scientists and expert reporters.
Psychiatric disorders such as depression and schizophrenia are an enormous cause of disability throughout the world. Yet most current medications are no better than drugs discovered more than half a century ago, and some pharmaceutical companies seem to be giving up. Why has progress in this area been so difficult? Are there any encouraging treatments on the horizon? What new approaches and technologies have the potential to break psychiatric medicine out of this rut?
Join us for a live chat at a special time this week, 3 p.m. EDT on Wednesday, 10 October, on this page. You can leave your questions in the comment box below before the chat starts. The full text of the chat will be archived on this page.
Save to my calendar
You might also like:
Thomas R. Insel
Thomas R. Insel, M.D., is director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health charged with generating the knowledge needed to understand, treat, and prevent mental disorders. His tenure at NIMH has been distinguished by groundbreaking findings in the areas of practical clinical trials, autism research, and the role of genetics in mental illnesses.
Steven E. Hyman
Steven E. Hyman, M.D. is the director of the Stanley Center for Psychiatric Research at the Broad Institute of Harvard and MIT in Cambridge, Massachusetts. The Stanley Center works on the genetics of schizophrenia, bipolar disorder, and autism, and on putting the genetics to work to understand the molecular mechanisms of disease and to facilitate the development of new therapies.
Greg Miller is the San Francisco, California, news correspondent for Science. He focuses on neuroscience and other areas of biological, behavioral, and social science.